ATC Index
Explore Cyclosporine, a potent immunosuppressant widely used to prevent organ rejection and treat severe autoimmune diseases. Learn its benefits, dosage, and side effects.
Browse our catalog for available pharmaceutical products and competitive pricing.
Cyclosporine is a powerful immunosuppressive drug widely utilized in modern medicine to prevent organ rejection following transplantation and to manage various autoimmune disorders. It belongs to a class of drugs known as calcineurin inhibitors, which work by suppressing the body's immune response. Its discovery marked a significant breakthrough in transplant medicine, dramatically improving the success rates and long-term outcomes for transplant recipients by preventing the immune system from attacking the new organ.
Discovered in 1970 from the fungus Tolypocladium inflatum (now known as Beauveria nivea), Cyclosporine was first approved for medical use in the early 1980s. Its introduction revolutionized organ transplantation, offering a viable solution to the critical challenge of immune-mediated rejection. Prior to Cyclosporine, transplant recipients faced a much higher risk of their bodies rejecting the transplanted organ, leading to graft failure and severe complications. The ability of Cyclosporine to selectively target T-lymphocytes, key players in the immune rejection process, without causing widespread bone marrow suppression, made it an invaluable therapeutic agent.
As a calcineurin inhibitor, Cyclosporine falls under the broader category of immunosuppressants. Its primary function is to dampen the immune system's activity, making it less aggressive towards perceived foreign bodies, such as transplanted organs, or less destructive in autoimmune conditions where the immune system mistakenly attacks the body's own tissues. The Anatomical Therapeutic Chemical (ATC) classification system assigns Cyclosporine the code D05, reflecting its role as a systemic immunosuppressant, specifically for use in dermatology (though it has many other systemic uses).
The immunosuppressive action of Cyclosporine is intricate and highly specific, primarily targeting T-lymphocytes, which are crucial mediators of the adaptive immune response. Upon entering the cell, Cyclosporine binds to a cytoplasmic protein known as cyclophilin. This Cyclosporine-cyclophilin complex then acts as an inhibitor of calcineurin, a phosphatase enzyme. Calcineurin is vital for dephosphorylating the nuclear factor of activated T-cells (NF-AT), which is a transcription factor. Once dephosphorylated, NF-AT translocates to the nucleus, where it initiates the transcription of various cytokine genes, most notably interleukin-2 (IL-2).
By inhibiting calcineurin, the Cyclosporine-cyclophilin complex prevents the dephosphorylation and subsequent nuclear translocation of NF-AT. This blockade effectively curtails the transcription of IL-2 and other pro-inflammatory cytokines such as IL-3, IL-4, TNF-alpha, and GM-CSF. Since IL-2 is a critical growth factor for T-lymphocytes, its reduced production and release lead to a significant decrease in T-cell proliferation and activation. Consequently, the cellular immune response, which is primarily responsible for graft rejection and autoimmune pathology, is suppressed without causing significant myelosuppression, thereby preserving other components of the immune system to some extent.
Cyclosporine is a cornerstone in the management of conditions requiring immune suppression. Its primary role is to prevent the body's immune system from rejecting transplanted organs, but its utility extends to a broad range of autoimmune diseases where the immune system mistakenly attacks healthy tissues. The effectiveness of Cyclosporine in modulating T-cell activity makes it invaluable in situations where a dampened immune response is therapeutically beneficial.
The dosage of Cyclosporine is highly individualized and depends on the specific indication, patient's weight, age, kidney function, and concomitant medications. It is crucial for patients to adhere strictly to their prescribed regimen and never adjust the dose without consulting their healthcare provider. Regular blood tests are often required to monitor Cyclosporine levels (therapeutic drug monitoring) to ensure efficacy and minimize toxicity, as the drug has a narrow therapeutic index.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Organ Transplant Prophylaxis | Initial: 10-15 mg/kg/day | Twice daily (divided doses) | Oral / IV |
| Rheumatoid Arthritis | Initial: 2.5 mg/kg/day | Twice daily (divided doses) | Oral |
| Psoriasis | Initial: 2.5-5 mg/kg/day | Twice daily (divided doses) | Oral |
| Nephrotic Syndrome | Initial: 2.5-5 mg/kg/day | Twice daily (divided doses) | Oral |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition, and may be adjusted based on therapeutic drug monitoring results and clinical response.
Like all potent medications, Cyclosporine is associated with a range of side effects, some of which can be serious. Careful monitoring by a healthcare professional is essential to manage these effects and ensure the safe use of the drug. The incidence and severity of side effects can vary among individuals.
Cyclosporine is metabolized by the cytochrome P450 3A4 (CYP3A4) enzyme system and is a substrate for P-glycoprotein. This makes it highly susceptible to interactions with numerous other medications and even some foods, which can significantly alter its blood levels, leading to either toxicity or reduced efficacy. Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking.
The use of Cyclosporine is contraindicated or requires extreme caution in certain patient populations and clinical situations due to its potent immunosuppressive and nephrotoxic properties.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.
Cyclosporine can be used long-term, particularly in organ transplant recipients where lifelong immunosuppression is often necessary. However, long-term use requires continuous monitoring for potential side effects such as kidney damage, hypertension, and an increased risk of infections and certain cancers. Regular blood tests, blood pressure checks, and follow-ups with your healthcare provider are essential to manage these risks and ensure the continued safe use of Cyclosporine.
The absorption of Cyclosporine can be influenced by food. It is generally recommended to take Cyclosporine consistently, either always with food or always without food, to maintain stable blood levels. Some formulations may recommend taking it on an empty stomach or with a light, consistent meal to optimize absorption. Avoid grapefruit or grapefruit juice entirely while on Cyclosporine, as it can significantly increase drug levels and lead to toxicity. Always follow the specific instructions provided by your pharmacist or prescriber.
If you miss a dose of Cyclosporine, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up. Consistency in dosing is crucial for maintaining therapeutic blood levels, so contact your healthcare provider if you frequently miss doses or are unsure about what to do, as this could impact the effectiveness of your treatment or increase the risk of rejection.
Cyclosporine is a prescription-only medication. It cannot be purchased over-the-counter or without a valid prescription from a licensed healthcare professional. You can obtain Cyclosporine through licensed pharmacies, hospital pharmacies, or specialized transplant pharmacies, typically after a thorough medical evaluation and prescription by a physician. Be wary of any sources claiming to sell Cyclosporine without a prescription, as these are likely illicit and unsafe.
Chat on WhatsApp